Toggle Main Menu Toggle Search

Open Access padlockePrints

SDF-1 signaling: a promising target in rheumatic diseases

Lookup NU author(s): Dr Amanda Villalvilla Garcia, Dr Rodolfo Gomez


Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Introduction: Stromal cell-derived factor 1 (SDF-1) is a potent chemoattractant cytokine with various biological functions such as stem cell mobilization, inflammatory cell infiltration and angiogenesis. Therefore, it has also been implicated in several pathological processes, from ischemic conditions to cancer. Remarkably, SDF-1 and its receptors, CXCR4 and CXCR7, are also present in joint tissues, where they play a role in the pathogenesis of rheumatoid arthritis (RA) and osteoarthritis (OA).Areas covered: This review summarizes the physiological and pathological role of SDF-1 signaling and its involvement in RA and OA. That includes synovial inflammation, bone erosion, cartilage degradation and increased bone turnover. Although this cytokine could play different roles in these rheumatic diseases, specific and differentiated therapeutic targets in each process can be identified. Current therapeutic strategies to block SDF-1 signaling in several diseases and their possible use in rheumatic diseases are also discussed.Expert opinion: Emerging drugs that block CXCR4 or CXCR7 in different disorders may represent promising therapies for rheumatic disease via inhibition of key pathological events involved in the progression of RA and OA.

Publication metadata

Author(s): Villalvilla A, Gomez R, Roman-Blas JA, Largo R, Herrero-Beaumont G

Publication type: Review

Publication status: Published

Journal: Expert Opinion on Therapeutic Targets

Year: 2014

Volume: 18

Issue: 9

Pages: 1077-1087

Print publication date: 01/09/2014

ISSN (print): 1472-8222

ISSN (electronic): 1744-7631



DOI: 10.1517/14728222.2014.930440